Immunomodulatory properties of morphine and the hypothesised role of long-term opioid use in the immunopathogenesis of tuberculosis

Bibliographic Details
Title: Immunomodulatory properties of morphine and the hypothesised role of long-term opioid use in the immunopathogenesis of tuberculosis
Authors: Vipula R. Bataduwaarachchi, SMN Hansanie, Neesha Rockwood, Leon Gerard D'Cruz
Source: Frontiers in Immunology, Vol 14 (2023)
Publisher Information: Frontiers Media S.A., 2023.
Publication Year: 2023
Collection: LCC:Immunologic diseases. Allergy
Subject Terms: immunopathogenesis of tuberculosis, morphine, opioids, opioid receptors, toll-like receptors, immunosuppression, Immunologic diseases. Allergy, RC581-607
More Details: Epidemiological studies have shown high tuberculosis (TB) prevalence among chronic opioid users. Opioid receptors are found on multiple immune cells and immunomodulatory properties of opioids could be a contributory factor for ensuing immunosuppression and development or reactivation of TB. Toll-like receptors (TLR) mediate an immune response against microbial pathogens, including Mycobacterium tuberculosis. Mycobacterial antigens and opioids co-stimulate TLRs 2/4/9 in immune cells, with resulting receptor cross-talk via multiple cytosolic secondary messengers, leading to significant immunomodulatory downstream effects. Blockade of specific immune pathways involved in the host defence against TB by morphine may play a critical role in causing tuberculosis among chronic morphine users despite multiple confounding factors such as socioeconomic deprivation, Human immunodeficiency virus co-infection and malnutrition. In this review, we map out immune pathways involved when immune cells are co-stimulated with mycobacterial antigens and morphine to explore a potential immunopathological basis for TB amongst long-term opioid users.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1664-3224
Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2023.1265511/full; https://doaj.org/toc/1664-3224
DOI: 10.3389/fimmu.2023.1265511
Access URL: https://doaj.org/article/2e52376047594a6bbdf68c04f38ea660
Accession Number: edsdoj.2e52376047594a6bbdf68c04f38ea660
Database: Directory of Open Access Journals
More Details
ISSN:16643224
DOI:10.3389/fimmu.2023.1265511
Published in:Frontiers in Immunology
Language:English